Nika C. Gloyeske, M.D.

Professional Background

I started my career in private practice in Indianapolis. However, when the opportunity arose, I did not hesitate to become a faculty member at KU. I am excited to bring my unique set of skills to provide care to patients in the KC metro area. I am also excited to share those skills to help teach the next generation of pathologists about the unique and important challenges in the field.

• BS, Exercise Science , University of Iowa , Iowa City, IA
• MD, Doctor of Medicine , Ross University School of Medicine , Roseau , Dominica
• Residency, Anatomical and Clinical Pathology, The University of Kansas School of Medicine, Kansas City, Kansas
• Clinical Fellowship, Gynecologic and Breast Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA

• Educational Commission for Foreign Medical Graduates
• Medical License, Kansas State Board of Healing Arts

• American Society of Clinical Pathology, Member, 2018 - Present
• Kansas City Pathology Society, Member, 2018 - Present
• United States and Canada Academy of Pathology , Member, 2010 - Present
• College of American Pathologists, Member, 2008 - Present

---

Research

Overview

Currently, I am working on a research collaboration that involves looking at extravillous trophoblast and placental implantation. I am collaborating with Dr. Paul and identifying appropriate placenta samples for analysis from patients with reported fetal growth restriction.

• Cortez Granados Samuel, Batsch Jonathan, Lui Asona, Hessman Jacob, Gloyeske Nika, Panchal Apurva. 2020. A rare case of group A streptococcal toxic‐shock syndrome in a postpartum adolescent leading to multi‐organ failure. Clinical Case Reports, 8 (5), 793-797. https://doi.org/10.1002/ccr3.2799
• Ratri A, Mickelsen R, Gray M, Gloyeske NC, Marsh CA, Christenson LK. 2020. Fibrotic Changes in Transgendger Ovaries Due to Testosterone Exposure. Fertility and Sterility, 114 (3)
• Linkov F, Elishaev E, Gloyeske NC, Edwards R, Althouse AD, Geller MA, Svendsen C, Argenta PA. 2014. Bariatric surgery-induced weight loss changes immune markers in the endometrium of morbidly obese women. Surgery for Obesity and Related Diseases, 10 (5), 921-926. https://doi.org/10.1016/j.soard.2014.03.023
• Argenta Peter, Svendsen Charles, Elishaev Esther, Gloyeske Nika, Geller Melissa A, Edwards Robert P, Linkov Faina. 2014. Hormone receptor expression patterns in the endometrium of asymptomatic morbidly obese women before and after bariatric surgery. Gynecologic Oncology, 133 (1), 78-82. https://doi.org/10.1016/j.ygyno.2013.12.005
• Gloyeske NC, Dabbs DJ, Bhargava R. 2014. Low ER+ breast cancer: Is this a distinct group?. American journal of clinical pathology, 141 (5), 697-701
• Argenta Peter, Svendsen Charles, Elishaev Esther, Gloyeske Nika, Geller Melissa A, Edwards Robert P, Linkov Faina. 2014. Hormone receptor expression patterns in the endometrium of asymptomatic morbidly obese women before and after bariatric surgery. Gynecologic Oncology, 133 (1), 78-82. https://doi.org/10.1016/j.ygyno.2013.12.005
• Shatat L, Gloyeske NC, Madan R, O'Neil M, Tawfik O, Fan F. 2013. Microinvasive breast carcinoma carries an excellent prognosis regardless of the tumor characteristics. Human Pathology, 44 (12), 2684-2689. https://doi.org/10.1016/j.humpath.2013.07.010
• Gloyeske NC, Goreal W, O'Neil M, Connor C, Tawfik OW, Fan F. 2011. Outcomes of breast cancer patients with micrometastases and isolated tumor cells in sentinel lymph nodes.. In vivo (Athens, Greece), 25 (6), 997-1001
• Laury RJ, Gloyeske N, Mettman D, Wagner JL, Fan F. 2022. Intraoperative sentinel lymph node evaluation in patients with node-positive breast cancer status post neoadjuvant systemic therapy - An institutional experience. Annals of Diagnostic Pathology, 60, 152012. https://doi.org/10.1016/j.anndiagpath.2022.152012
• Liebscher Sean C, Kilgore Lyndsey J, Winblad Onalisa, Gloyeske Nika, Larson Kelsey, Balanoff Christa, Nye Lauren, O’Dea Anne, Sharma Priyanka, Kimler Bruce, Khan Qamar, Wagner Jamie. 2023. Use of Ultrasound and Ki–67 Proliferation Index to Predict Breast Cancer Tumor Response to Neoadjuvant Endocrine Therapy. Healthcare, 11 (3), 417. https://doi.org/10.3390/healthcare11030417